Stock Ratings / Financials / NMR / insiders

TW (76) RJF (69) LPLA (38) CBOE (78) ⌘ Pro Terminal →

Nomura Holdings Inc ADR (NMR) Insider, 13F Hedge Fund & Politician Buy/Sell Thermometer

$9.38 -0.95% NYSE • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $9.35

Nomura Holdings Inc ADR (NMR) carries a Roarable Rating of D+ (Sell) with 56/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

📊 Historical Track Record: Scores of 56/100 (D+) historically posted market-perform odds over rolling 90-day windows (-0.4% avg 90D alpha vs SPY) →

ROARABLE D+ • SELL / AVOID Cap $27.48B

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on NMR Below — or Connect Your Own ChatGPT / Claude

🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is NMR stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

▼

As of 2026-11-02, Nomura Holdings Inc ADR (NYSE: NMR) is rated D+ (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 56/100 at a spot price of $9.38 (-0.95% 1D, market cap $27.48B). Pillar breakdown: Fundamental Cash Engine 11/20, Institutional 13F & Options Flow 9/20, Executive Insider Alignment 15/20, FRED Macro Regime Fit 9/20, and SEC Balance-Sheet Forensics 12/20. Across 1096 tracked Financials issuers, NMR ranks #528 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief

🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does NMR compare to TW and RJF in the Financials sector?

▼

Within the Financials sector (Investment Bankers/Brokers/Service), NMR carries a Roarable D+ (56/100 RQD), trailing P/E of 32.8x, gross margin of —, and ROIC of 9.9%. By comparison, TW (Tradeweb Markets Inc.) holds a B+ grade (76/100 RQD, P/E 34.2x, ROIC 13.6%, cap $27.82B) and RJF (Raymond James Financial Inc.) posts a C+ grade (69/100 RQD, P/E 14.5x, ROIC 5.9%, cap $31.03B). Among the 5-stock peer group, RJF leads on earnings multiple (14.5x) while CBOE leads on capital efficiency (26.6% ROIC).

✓ Pre-computed one-to-many AI Quant brief

🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for NMR?

▼

For Nomura Holdings Inc ADR (NMR), key quantitative strengths include Clean SEC annual filing review with no major hidden accounting time-bombs. and sector rank #528 in Financials, while primary risk factors center on Sensitive to high interest rates and tighter Federal Reserve market liquidity. and implied 5-year growth hurdle of 25.3%/yr. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief

🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $9.35 (-0.36%)🧬 Cannibal Buyback (-1.24% YoY Shares)⚙️ Cash Engine: 11/20 (D+) • 15.2% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record: Scores of 56/100 (D+) historically posted market-perform odds over rolling 90-day windows (-0.4% avg 90D alpha vs SPY • 51.8% hit rate — wait for RQD ≥ 70 breakout).

Audit Bucket Track Record →

RQD QUANT TACHOMETERSELL / AVOID • D+

JEV AI Jury Split (Battleground)

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw D+ · Rk C-

Each axis scored 0–20

12M PRICE TARGET CONE-0.9% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for NMR)Realized 20D OHLCV Swing Band: ±4.3%

Deterministic 5-Pillar Attribution (56/100 Composite)

🔍 WHY NMR SCORES 56/100 (D+) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: SEC 10-K Forensic Risk+15/20 pts (27% of score)

Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 7/9

▲ #2 Bullish Driver: Insider Conviction & Share Dilution+12/20 pts (21% of score)

SEC Form 4 / 13F Thermometer: 60% Net Buy • Cannibal Buyback (-1.24% YoY Shares)

▼ #1 Drag / Risk Factor: Macro Regime Fit9/20 pts (-11 pt drag)

Macro rate sensitivity & RSI-14 (50.8) create a -11 pt regime headwind

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade C+$9.58-4.7% Next Q

Q2 (-2Q)

Grade C$9.13-0.2% Next Q

Q3 (-1Q)

Grade C$9.11+3% Next Q

Current

Grade D+$9.38-0.4% Hist 90D α

Trajectory: C+ (64) → D+ (56)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER

⚔️ Adversarial Opposing Case: Why the NMR Bull Thesis Could Fail

Gideon Ashmere Forensic Desk →

Even with a 56/100 (D+) score, NMR faces multiple-compression risk if 32.8x trailing P/E re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.

⚠️ Forensic Kill-Switch #1

Sensitive to high interest rates and tighter Federal Reserve market liquidity.

⚠️ Forensic Kill-Switch #2

Dilution & Margin Drag: Cannibal Buyback (-1.24% YoY Shares) — any gross margin slip below 49.5% triggers an automatic RQD downgrade.

⚠️ Forensic Kill-Switch #3

Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($9.83) or 200D SMA ($9.00) invalidates the momentum regime and cuts Target Base ($9.30) toward Bear Floor ($7.25).

🎲 LIVE PREDICTION MARKET ODDS TIED TO $NMR• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “NMR Beats Next Quarter EPS Consensus (Upcoming Quarter) & Holds Above 200D SMA”

YES 56%NO 44%Trade / Inspect Odds →

SEC FORM 4 × 13F HEDGE FUNDS × CONGRESSIONAL STOCK ACT

NMR Smart-Money Thermometer: BALANCED INSTITUTIONAL POSITIONING

Explore All 13F & Congress Whales →

▲ Disclosed Buys: 0 ($0)▼ Disclosed Sales: 0 ($0)

Wide-Open SEC Form 4, 13F & Congressional Disclosure Ledger (NMR)

No recent open-market Form 4 cluster sales or emergency dumps flagged on NMR. Visit the Global 13F & Congressional Whale Ledger for cross-market smart-money filings.

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring NMR)

✓Walkthrough of NMR's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

NMR // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +20.72%📐 HORIZONTAL RANGE

2026-11-02O $9.12H $9.47L $9.12C $9.38VOL 2.63M

RES: $11.73SUP: $8.85SMA50: $9.83SMA200: $9.00

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

NMR Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 NMR Butterfly Map → + Track NMR →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

25.3%/yr Implied 5Y Growth

vs. 0.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on NMR today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for NMR. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for NMR today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (NMR)

Financials Rank #528 of 1096 ⚔️ TW vs NMR Full Matrix →

1. Head-to-Head Financials Peer Comparison (NMR vs. TW, RJF, LPLA, CBOE)

Industry: Investment Bankers/Brokers/Service (64 Tracked Issuers)

Across 1096 tracked Financials securities in the Roarable RQD universe, Nomura Holdings Inc ADR (NMR) ranks #528 by composite RQD confidence (56/100, grade D+) and #100 by equity capitalization ($27.48B). Within this direct 5-issuer industry benchmark cohort, RJF leads on earnings valuation at 14.5x trailing P/E, while CBOE leads on capital efficiency and profitability with 26.6% ROIC and — gross margin. CBOE currently holds the highest overall quantitative score in the immediate peer group at 78/100 (B+) compared with NMR at 56/100 (D+).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
NMR ACTIVE Nomura Holdings Inc ADR	D+	56/100	32.8x	—	9.9%	-0.95%	$27.48B	Benchmark Subject
TW Tradeweb Markets Inc.	B+	76/100	34.2x	—	13.6%	+3.08%	$27.82B	/tw-vs-nmr →
RJF Raymond James Financial Inc.	C+	69/100	14.5x	—	5.9%	-2.52%	$31.03B	/rjf-vs-nmr →
LPLA LPL Financial Holdings Inc.	D-	38/100	25.5x	—	8.5%	+1.50%	$22.01B	/lpla-vs-nmr →
CBOE Cboe Global Markets Inc.	B+	78/100	31.9x	—	26.6%	+6.77%	$35.14B	/cboe-vs-nmr →

2. NMR Fundamental Profitability, Capital Efficiency & Balance-Sheet Forensics

TRAILING 12M & FORWARD QUANTITATIVE SNAPSHOT

Nomura Holdings Inc ADR (NMR) operates in Investment Bankers/Brokers/Service (Financials) with an equity capitalization of $27.48B, trailing P/E of 32.8x, forward P/E of 30.5x, and EV/EBITDA of 21.0x. Operating profitability registers a gross margin of —, operating margin of 13.9%, net profit margin of 10.9%, ROIC of 9.9%, and free cash flow yield of 2.21%, alongside an Altman Z-Score of N/A and Piotroski F-Score of 7/9.

3. NMR Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is NMR stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

How does NMR compare to TW and RJF in the Financials sector?

What are the biggest fundamental strengths and SEC risk factors for NMR?

Where is NMR trading relative to its 50-day, 200-day, and 52-week technical levels?

NMR last traded at $9.38 (-0.95% on volume of 2,482,261 shares), positioning the stock -4.58% below its 50-day simple moving average ($9.83) and +4.22% above its 200-day simple moving average ($9.00). Across its 52-week range of $6.88 to $10.94, NMR sits at the 61.6% percentile with a 14-day RSI of 50.8 (NEUTRAL RANGE) and an implied next-earnings move of ±4.3% ($8.98 to $9.78).

NMR Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

Are NMR insiders and hedge funds buying or selling?

Roarable's SEC Form 4 and 13F Whale Thermometer currently classifies NMR leadership and institutional positioning as: BALANCED INSTITUTIONAL POSITIONING.

Direct Sub-Reports: NMR RQD Cockpit NMR 12M Forecast NMR Earnings & Move NMR Dividends & DRIP NMR Insiders & 13F NMR Whale Options NMR Profit Sankey NMR News & Why

ROARABLE RATING BRIEF • RQD 56/100 (D+) ✓ STAGE-C NUMBER FIREWALL VERIFIED

NMR — Nomura Holdings Inc ADR: What the Facts Mean to a Prospective Investor

Engine: anthropic/claude-haiku-5.5

As of: 2026-11-02T14:09:22Z

Roarable Rating Brief: What This Means to a Prospective Investor

Per the Roarable RQD rating, NMR scores 56 out of 100, a letter grade of D+, with the verdict label "Roarable Sell — Weak Fundamentals / Trim." The five pillars are: Fundamental Cash Engine at 11 / 20 (ROIC 9.9%; FCF yield 2.21%), Whale 13F Flow at 9 / 20 (institutional accumulation and options positioning), Insider Conviction at 12 / 20 (SEC Form 4 and Congressional PTR cluster flow), Macro Regime Fit at 9 / 20 (Beta 1.15; sector sensitivity), and Forensic Balance Sheet at 15 / 20 (Altman Z 2.5; Piotroski F 7/9; Debt/Equity 0.5).

For a prospective investor, the rating indicates that the cash-generation pillar and the macro-sensitivity pillar are the weakest contributors, with the balance-sheet pillar as the strongest. A 2.21% FCF yield alongside a 30.5 forward P/E frames a valuation tradeoff: the market is pricing in substantial future earnings relative to current free cash flow. The Beta of 1.15 implies above-market sensitivity to broad market moves per the market data section. Recent news flow carries RED-flagged earnings-miss headlines, which align with the lower fundamental and macro pillar scores. The verdict is a rating-system output and is presented here for analytical context, not as a recommendation.

Snapshot

Price	Market Cap	P/E (TTM)	Forward P/E	EV/EBITDA	EPS (TTM)	Dividend Yield	Beta	52-Wk Range	ROIC %
9.47	$27.48B	32.8	30.5	21	0.29	0%	1.15	$6.88 - $10.94	9.9%

Business

Nomura Holdings Inc ADR (NMR) is a NYSE-listed issuer in the Financials sector, Investment Bankers/Brokers/Service industry, per the profile section. Not available in source data for product lines, customer segments, or revenue model detail beyond sector and industry classification.

Recent Catalysts & News Wire Analysis

Per the recent news and catalysts section, the most recent headlines report that Nomura ADR earnings missed and revenue fell short of estimates; these are flagged RED with a RISK WATCH impact label across multiple regional Investing.com syndications. A Form 4 filing by director Masahiro Ishizuka (filing reference dated 23 October) is flagged YELLOW with a MARKET WIRE label. An earnings call transcript headline describes strong H1 2026 profit with shares rising, flagged YELLOW with a MARKET WIRE label. The headlines are syndicated versions of overlapping stories, so they should be read as a small set of distinct events rather than independent confirmations.

Per the Butterfly Supply-Chain Graph, the supply chain is recorded as NONE, with no butterfly links and no proprietary signals.

Open Questions

What are the reported revenue, operating income, and net income figures for recent periods, and how do they compare with the earnings-miss headlines?
What are the analyst consensus rating and price targets for NMR?
What institutional (13F) and insider (Form 4, Congressional PTR) holdings and trade sizes underlie the Whale and Insider pillar scores?
What is the company's regional revenue and business-line mix, and how does its exposure to the H1 2026 profit results relate to the reported miss?
What is the basis for the 0% gross margin and 0% dividend yield reported in the market data?

NMR Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for Nomura Holdings Inc ADR (NMR) • Click "Debate This Headline" to argue it in the Roar Pit below

💬 Jump to NMR Debate Forum (3) ↓

🔴 RISK WATCH Investing.com • 8h ago

Nomura ADR earnings missed, revenue fell short of estimates

Investing.com report covering Nomura Holdings Inc ADR (NMR) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🔴 RISK WATCH Investing.com South Africa • 11h ago

Nomura ADR earnings missed, revenue fell short of estimates By Investing.com

Investing.com South Africa report covering Nomura Holdings Inc ADR (NMR) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Investing.com Nigeria • 17h ago

Form 4 NOMURA HOLDINGS INC: Masahiro Ishizuka (Director) For: 23 October

Investing.com Nigeria report covering Nomura Holdings Inc ADR (NMR) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Investing.com India • 20h ago

Earnings call transcript: Nomura Holdings posts strong H1 2026 profit, shares rise

Investing.com India report covering Nomura Holdings Inc ADR (NMR) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Yahoo • 2d ago

BOJ speeds up ETF sales, potentially boosting funding for Takaichi’s plans

Investing.com -- The Bank of Japan’s decision to accelerate sales of its exchange-traded fund holdings could generate additional government revenue, potentially helping Prime Minister Sanae Takaichi finance her ambitious

Read Full Source ↗

🟡 MARKET WIRE SeekingAlpha • 3d ago

Nomura Holdings, Inc. 2027 Q2 - Results - Earnings Call Presentation

2026-10-30. The following slide deck was published by Nomura Holdings, Inc.

Read Full Source ↗

🟢 CATALYST Yahoo • 3d ago

Nomura (TSE:8604) Q2 Earnings Highlight Margin Pressure Beneath Revenue Growth

The market has already cooled on Nomura Holdings. The stock is roughly flat over the past week and down over the last three months, even after the latest numbers hit the tape. Q2 2027 earnings landed with group net reven

Read Full Source ↗

🟢 CATALYST Yahoo • 4d ago

NMR Q2 Earnings Call Highlights Wealth Growth and Cost Pressures

Nomura's record Wealth Management recurring revenues and rising bond demand bolster growth, while Wholesale costs remain a hurdle to its profitability goals.

Read Full Source ↗

🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE 3 Active Posts & Replies

NMR Bull vs. Bear Conversation Board — What's Your Call at $9.38?

🐂 50% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON NMR 🐻 50% BEARISH CONVICTION

RO RoarDesk_Moderator Roarable Research Desk ⚖️ DEBATE HOST 🎯 Target: $10.23 (+8.0%)

📌 Pinned Debate

🔥 Official Bull vs. Bear Debate: Is NMR (D+ • RQD 56/100) a Buy at $9.47?

Welcome to the NMR (Nomura Holdings Inc ADR) Roar Pit. Current RQD Composite is 56/100 (Roarable Sell — Weak Fundamentals / Trim) in Investment Bankers/Brokers/Service. Bulls point to operating leverage and sector positioning, while bears focus on valuation multiple compression (32.8x trailing P/E). Pick your side (🐂 Bull or 🐻 Bear) and drop your price target below.

BE BearTrap_Alert Forensic Accounting Watch 🐻 BEARISH 🎯 Target: $7.10 (-25.0%)

Spot @ $9.47

Pump the brakes on NMR — check the valuation vs. margin headwinds

Everyone in here is repeating the bull case on NMR, but look at what you are paying: 32.8x trailing P/E with tightening sector spreads. Unless Nomura Holdings Inc ADR expands free cash flow yield next quarter, I would rather wait for a pullback closer to the 200-day moving average before touching this.

MI MidwestValue Verified K Arena Trader 🐂 BULLISH 🎯 Target: $11.17 (+18.0%)

Spot @ $9.47

NMR cash flow & RQD setup is being underpriced by the Street here

Looking at the 5-pillar RQD breakdown on NMR, the market is fixating on short-term headline noise in Investment Bankers/Brokers/Service and ignoring the balance sheet and cash flow trajectory. At $9.47 (52-wk range $6.88 - $10.94), any beat on forward guidance forces shorts and underweight funds to chase.